Skip to main content
Premium Trial:

Request an Annual Quote

TGen to Use GE Healthcare’s IN Cell Analyzer for Cancer Research

NEW YORK (GenomeWeb News) - GE Healthcare said today that it has entered into a strategic alliance with the Translational Genomics Research Institute in which TGen will apply its IN Cell Analyzer 1000 and 3000 to cancer research.
"This collaboration could result in a better understanding of the biological mechanisms involved in oncology, many of which are not currently well understood by the medical community," said Spyro Mousses, director of pharmaceutical genomics and cancer drug development at TGen, in a statement.
TGen expects to use GE's cellular imaging systems to observe cellular morphology and perform cytometry. "Most importantly, we can more accurately collect multi-parametric information about how cells are responding to specific genetic perturbations and to specific drug exposures," Mousses said.
Financial terms of the agreement were not disclosed.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.